Selecting Promising Treatments in Randomized Phase II Cancer Trials with an Active Control

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.19, Iss.3, 2009-05, pp. : 494-508

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized Phase II Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 4, 2014-07 ,pp. : 802-816

Taylor & Francis Ltd

Access to resources Recommend Favorite

Between-Arm Comparisons in Randomized Phase II Trials

By Jung Sin-Ho George Stephen

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 456-468

Taylor & Francis Ltd

Access to resources Recommend Favorite

Optimal Two-Stage Randomized Multinomial Designs for Phase II Oncology Trials

By Sun Linda

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 485-493

Taylor & Francis Ltd

Access to resources Recommend Favorite

Design of Phase II Cancer Trials for Evaluation of Cytostatic/Cytotoxic Agents

By Kocherginsky Masha Cohen Ezra Karrison Theodore

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 3, 2009-05 ,pp. : 524-529

Taylor & Francis Ltd

Access to resources Recommend Favorite

Promising data from ixabepilone cancer trials

Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite